Počet záznamov: 1
proteíny nádorové
SYS d009363 LBL 00000nz--a2200000o--4500 005 20250606213312.0 008 990101|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a D12.776.624 066 $a 01 $c 03 150 $a proteíny nádorové $x AD $x AE $x AG $x AI $x AN $x BI $x BL $x CF $x CH $x CL $x CS $x DE $x DF $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UL $x UR $2 slo 550 $7 sllk_us_auth*d000951 $Y Antigens, Neoplasm $w p $a antigény nádorové 550 $7 sllk_us_auth*d014408 $Y Biomarkers, Tumor $w p $a biomarkery nádorové 550 $7 sllk_us_auth*d052138 $Y Genes, Neoplasm $w b $a gény nádorové 680 9-
$i Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. $2 eng 680 $a IM & coord with specific protein (IM) + specific histol type (IM) + specific organ/neoplasms term (IM); Manual 24.4.4.4 $2 eng 750 -2
$a Neoplasm Proteins $2 eng 980 $x M
Počet záznamov: 1